Vision transformer-based model can optimize curative-intent treatment for patients with recurrent hepatocellular carcinoma
Abstract The treatment selection for recurrent hepatocellular carcinoma (rHCC) within Milan criteria after hepatectomy remains challenging. Here, we present HEROVision, a Vision Transformer-based model designed for personalized prognosis prediction and treatment optimization between thermal ablation...
Saved in:
| Main Authors: | Ke Zhang, Jinyu Ru, Wenbo Wang, Qiuping Ma, Fengwei Gao, Jiapeng Wu, Zhifei Dai, Qingyun Xie, Lei Mu, Haoyan Zhang, Jinhua Pan, Liting Xie, Qiyu Zhao, Jie Tian, Jie Yu, Ping Liang, Hong Wu, Kai Li, Wei Yang, Kun Wang, Tianan Jiang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-05-01
|
| Series: | Nature Communications |
| Online Access: | https://doi.org/10.1038/s41467-025-59197-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Preoperative platelet-to-lymphocyte ratio is a valuable prognostic biomarker in patients with hepatocellular carcinoma undergoing curative liver resection
by: Hao-Jie Yang, et al.
Published: (2017-06-01) -
Risk factors of early recurrence after curative hepatectomy in hepatocellular carcinoma
by: Young Mi Hong, et al.
Published: (2017-10-01) -
Surveillance Patterns After Curative-Intent Colorectal Cancer Surgery in Ontario
by: Jensen Tan, et al.
Published: (2014-01-01) -
Case-Based Approach to Detect Cancer in Women with Curative Intent at Beginning
by: Imran Majeed, et al.
Published: (2024-10-01) -
Predictive Radiomics-Based Model for Recurrence-Free Survival After Curative Resection in Patients with Hepatocellular Carcinoma
by: Cui J, et al.
Published: (2025-08-01)